TOP 10 AMONG
LARGEST RUSSIAN DISTRIBUTORS

Our objective is to render maximum assistance in preserving the health and increasing the lifespan of Russian patients. GDP strives to make cutting-edge medical developments available to this country’s population in the shortest possible time frame.

538

employees

323

direct contracts

6

years of successful wholesale supply operations

Participant of the
14 High-Cost Nosologies state programme

Partner of the Ministry of Health of Russian Federation and regional healthcare departments

Mission

To provide the healthcare system of the Russian Federation with effective pharmaceuticals, modern medical equipment and quality medical products.

Wide range
of innovative products
Product
safety
Adherence
to deadlines
Regional
coverage
Technological leadership
in warehouse logistics

GOOD
DISTRIBUTION
PARTNERS

2016

2018

2019

January 2020

July 2020

December 2020

GDP takes over a 30,300 sq m office-and-warehouse complex for medication wholesale. The complex is located in the Belye Stolby micro-district in the Domodedovsky District of the Moscow Region, within the South Gate industrial park.

Oleg Kovalev is appointed GDP Chief Executive

As of the first half of the year, GDP features in the RNC Pharma rating of suppliers, ranking ninth with a 2.9% share of direct supplies, including both commercial and state-financed segments

GDP strengthens its senior management: Andrey Telyatnikov is appointed Deputy CEO for Commerce

GDP enters the state-financed market in the second half of the year

Deliveries are made to 46 regions of Russia

At year-end, GDP holds a 2.7% market share according to analytical company RNC Pharma

Pharmaceuticals are delivered to all Russian regions

The company enters the 14 High-Cost Nosologies market

GDP wins the bidding to supply the Ministry of Health with Alemtuzumab for disseminated sclerosis patients within the 14 High-Cost Nosologies programme, under a contract worth RUB 573.4 mn.

Pharmaceuticals are delivered to all Russian regions

According to RNC Pharma, as of the first half of the year, GDP ranks 9th with a market share of 2.2%

Pharmaceuticals are delivered to all Russian regions

Development strategy

To enter the top 5 largest distributors in Russia within three years
To develop the state-financed line of business and to increase regional presence
To expand into all segments of the state-financed market with a focus on procurement for compulsory health insurance

Select your region